Researchers have shown, for the first time, how the genetic material of the Nipah virus replicates in infected cells. The ...
The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...
As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...
3d
AZoLifeSciences on MSNCryo-EM Reveals 3D Structure of Nipah Virus RNA PolymeraseThe replication of the Nipah virus's genetic material in infected cells has been demonstrated for the first time by ...
A collaboration between researchers in the Brazilian states of São Paulo and Ceará and colleagues affiliated with Hong Kong ...
The H5N1 Avian Bird Flu has been the talk of many health departments and agencies around the state of Indiana the last few ...
The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases. But some conservatives are ...
Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...
3d
Verywell Health on MSNHow Long Do Cold and Flu Germs Live on Surfaces?Cold germs from someone’s nose or cough can live on surfaces for hours to days, depending on many factors. Learn which ...
ICMR-NIV director discusses India's expanding VRDL network, vaccine manufacturing, viral disease surveillance, and One Health ...
1d
GlobalData on MSNViiV to trial twice-yearly HIV antibody dosing after Phase IIb successThe company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results